We are live on ! Find out more
CIA

CCM Investment Advisers Portfolio holdings

AUM $1.04B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+14.97%
1 Year Est. Return
+40.82%
3 Year Est. Return
+117.67%
5 Year Est. Return
+151.7%
10 Year Est. Return
+485.69%
AUM
$836M
AUM Growth
+$23.6M
Cap. Flow
-$69.4M
Cap. Flow %
-8.3%
Top 10 Hldgs %
28.92%
Holding
78
New
3
Increased
12
Reduced
54
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.3M
2
LLY icon
Eli Lilly
LLY
+$9.63M
3
EQIX icon
Equinix
EQIX
+$7.6M
4
NFLX icon
Netflix
NFLX
+$3.34M
5
PG icon
Procter & Gamble
PG
+$1.04M

Top Sells

Rank Stock Value
1
OMC icon
Omnicom Group
OMC
+$13.5M
2
CVS icon
CVS Health
CVS
+$12.8M
3
GILD icon
Gilead Sciences
GILD
+$10M
4
O icon
Realty Income
O
+$6.81M
5
TSN icon
Tyson Foods
TSN
+$5.69M

Sector Composition

Rank Sector Weight
1 Technology 28.95%
2 Healthcare 12.5%
3 Financials 12.21%
4 Consumer Discretionary 10.45%
5 Communication Services 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$132B
– –
-16,009
Closed -$821K
RTX icon
77
RTX Corp
RTX
$302B
– –
-4,254
Closed -$358K
1 2 3
4

Similar funds

HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
WP
Waycross Partners Louisville, Kentucky $1.05B AUM 20.92% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
RC
RDST Capital Seattle, Washington $1.04B AUM 0.4% 1-Year Est. Return

CCM Investment Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, CCM Investment Advisers held 78 positions worth $836M, up 2.9% from $813M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

CCM Investment Advisers withdrew a net $69.4M in Q1 2024, closing 3 positions and reducing 54 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $821K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

Against the trend, CCM Investment Advisers opened a new position in Vertex Pharmaceuticals worth $12.2M.

  • CCM Investment Advisers's largest Q1 2024 buy was Vertex Pharmaceuticals: 29,185 shares worth $12.2M.
  • CCM Investment Advisers added most to Eli Lilly in Q1 2024, an estimated $9.63M increase.
  • CCM Investment Advisers's biggest Q1 2024 reduction was Omnicom Group, cutting an estimated $13.5M.
  • CCM Investment Advisers fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $821K.
  • CCM Investment Advisers's ten largest holdings make up 29% of its $836M portfolio in Q1 2024.
  • CCM Investment Advisers opened 3 new positions and closed 3 in Q1 2024.
  • CCM Investment Advisers's portfolio value rose 2.9% quarter-over-quarter to $836M.

Based on CCM Investment Advisers's 13F filing for Q1 2024, filed 17 May 2024.